GSK Turns to Chinese Medicine for Drug Discovery - Feb. 13, 2012

Monday, February 13, 2012  |   |   |   |  From concept through clinical trial, Myriad RBM has the biomarkers, the platform and the expertise to guide your biomarker strategy. With our menu of over 400 quantitative biomarkers and proven successes in CNS, Oncology, Toxicology, Inflammation, Cardiovascular diseases, Immunology, Metabolism and many other therapeutic areas, our services can give you the insight you need to realize your biomarker success story. To share your success story or to learn more, click here: www.myriadrbm.com/biomarkerbreakthrough/clinicaspace. •  GlaxoSmithKline (GSK) Turns to Chinese Medicine for Drug Discovery More... More Discontinuations News More Industry News •  Regeneca International, Inc. Recalls Specific Lot of RegenArouse Because of Potential Health Risks More... More Discontinuations News More Recalls and Warning News •  FDA Delays Approval for Novartis AG (NVS)' Menveo for Expanded Use in Infants, Toddlers More... •  Horizon Pharma, Inc. Modifies DUEXIS(R) Marketing Authorization Application to Include Recently Approved Manufacturing Site More... •  Watson Pharmaceuticals, Inc. (WPI) Confirms Beyaz(R) Patent Challenge More... •  Columbia Laboratories, Inc. (CBRX) Transfers NDA for Progesterone Vaginal Gel 8% to Watson Pharmaceuticals, Inc. (WPI) More... •  Amarin Corporation PLC (AMRN) Announces FDA Advisory Committee Will Not Be Scheduled in Connection With New Drug Application for AMR101 More... More BLA/NDA/ANDA News More IND News More MAA News •  ZIOPHARM Oncology, Inc. (ZIOP.OB) Reports Positive Preliminary Palifosfamide Overall Survival Data From Randomized Phase 2 Study in Soft Tissue Sarcoma More... •  Dynavax Technologies Corporation (DVAX) Release: Phase 3 Data on HEPLISAV(TM) in Adults Aged 18-55 Published in VACCINE More... •  Santarus Inc. (SNTS) Announces Initiation of Phase IIIb Study with UCERIS in Patients with Mild or Moderate Active Ulcerative Colitis More... •  Verinata Health, Inc. Announces Presentation and Publication of Top-Line Clinical Validation Study Results for its verifi(TM) Non-Invasive Prenatal Test More... •  Cyclacel Pharmaceuticals, Inc. (CYCC) Provides Update on Clinical Progress With Sapacitabine as Second Line Therapy in Older Patients With Myelodysplastic Syndromes More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News Building Novel Applications with Pipeline Pilot to Drive Next Generation Sequencing This case study shows how scientists are streamlining the process of analyses of DNA sequence information. Enabled by new DNA sequencing technologies, many more scientists and informaticians are interrogating larger and more complex data set. Request Now! •  Both Maternal and Paternal Age Linked to Autism, University of Texas Health Science Center Study More... •  Overeating Could Double Your Chance of Memory Loss, Mayo Clinic Study More... •  "Hunger Hormone" Could Help Chemo Patients, Osaka University Study More... •  With No Firm Science, Sleep Standards are Slipping, University of South Australia Study More... •  Kowa Pharmaceuticals America Release: New Study Data Published Assessing the Effect of LIVALO(R) vs. Crestor(R) on International Normalized Ratio on Steady-State Warfarin More... More General Clinical Research News SDIX Presents: Better Antibodies Through Better Antigen Design Thursday, March 8th | Bethesda, MD (www.sdix.com/learn) Friday, March 9th | King of Prussia, PA (www.sdix.com/discover) Join SDIX on March 8th or March 9th for a series of talks focused on next generation antibody development. At SDIX, a focus on the philosophy of better antigen design has resulted in dramatic improvements to the antibody production process. In a series of talks, our scientists will discuss this antigen design philosophy and provide case studies to demonstrate the effectiveness of this methodology. In particular, these talks will focus on the use of SDIX's proprietary Genomic Antibody Technology™ and its ability to deliver antibodies that match end users' requirements. To register and for more information, visit: March 8th in Bethesda, MD: www.sdix.com/learn. March 9th in King of Prussia, PA: www.sdix.com/discover. New Emerging R&D and Clinical Trial Locations • Compare 5 new emerging R&D locations in terms of population, economic activity, healthcare infrastructure, and current R&D activity. • Analyze how clinical trial numbers are changing in China, India, and Eastern Europe. • Develop strategies for geographic outsourcing. Click Here for More Information. • Biotech Beach (Irvine, California) AcuFocus, Inc. Clinical Research Associate Assist in planning, executing and monitoring of multi-site clinical protocols in accordance with ICH and GCP guidelines. Maintain IRB/EC/IACUC submissions, track approvals and completion of periodic reports • Biotech Bay (Redwood City, California) Genomic Health, Inc. Clinical Laboratory Scientist I Responsible for performing high complexity laboratory testing on patient specimens, interpreting and reporting patient results, performing quality control and quality assurance procedures and complying with all applicable local, state and federal laboratory requirements. • Bio NC (Durham, North Carolina) PAREXEL International Clinical Monitoring Associate Perform remote clinical monitoring tasks and remote visits for designated projects in accordance with relevant SOPs, study specific procedures and regulations. Responsibilities include managing/coordinating/supporting clinical monitoring activities remotely, including issue resolution, patient enrollment management, handling protocol- and/or ICF- and/or contract amendments, drug / supply management and ensuring timely data entry at a site level. • Genetown (Cambridge, Massachusetts) Pfizer, Inc. Clinical Pharmacology Lead Responsible for providing the clinical pharmacology components of Clinical Plans and provides clinical pharmacology expertise to the project team. Plans, designs and oversees clinical pharmacology studies as required throughout all stages of drug development with operational assistance from a Clinical Research Operations • Biotech Bay (San Francisco, California) Biotecher Senior Manager, Clinical Research Operations Support department head in oversight and management of US and ex-US clinical trials. Help ensure that US and ex-US clinical activities are GCP/FDA and/or ICH compliant and on track to meet deliverables. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Genetown Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Northeast region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Genetown Career Fair, Cambridge, MA February 21, 2012 • BioSpace Career Fair at CALBIO2012, San Francisco, CA March 7, 2012 • BioMidwest Career Fair, Bridgewater, NJ March 22, 2012 • Biotech Beach Career Fair, La Jolla, CA April 17, 2012 • BioCapital Career Fair, Bethesda, MD April 25, 2012 • Pharm Country Career Fair, King Of Prussia, PA May 1, 2012 • BioNC Career Fair, Durham, NC May 2, 2012 • Biotech Bay Career Fair, Burlingame, CA May 29, 2012 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  Plasticell Announces Grant of Fundamental Combicultt Patents in USA and Japan More... More Patent News •  Ben Venue Laboratories's Children Leukemia Drug May Run Out Within Weeks More... •  Amylin Pharmaceuticals, Inc. (AMLN) Release: BYDUREON(TM), First and Only Once-Weekly Type 2 Diabetes Treatment, Now Available in U.S. Pharmacies More... More Drug Product News Hot Company Gentris Corporation 133 Southcenter Court, Suite 400 Morrisville, North Carolina 27560 U.S.A. Phone: 919-465-0100 Fax: 919-465-0554 Gentris Corporation is a leading global provider of applied clinical pharmacogenomic services. As pioneers in the field of pharmacogenomics, Gentris assists pharmaceutical companies and clinical research organizations to effectively integrate pharmacogenomics into their drug development programs to deliver safer, more effective drugs to market more quickly. More Company Profiles Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Maysa Darwish, Tammy Liu, Michelle Wong ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2012 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.